Arena Pharmaceuticals ROCE Ratio 2011-2026 | ARNA

Annual ROCE Ratio Arena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-92.73	-37.67	42.75	-22.04	-34.45	-5.03	-50.03	-50.36	-8.52	-24.69	-58.0	-120.42	-185.59	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
42.75	-185.59	-49.75

Quarterly ROCE Ratio Arena Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-51.31	-51.31	-51.31	-51.31	-51.31	-59.76	-42.54	-38.26	-26.11	-33.03	-30.29	35.04	45.64	38.27	38.42	38.19	-25.38	-32.69	-51.57	-122.68	-117.38	-413.56	-592.29	-617.74	-540.69	-571.32	-300.27	-123.74	-72.63	-106.98	-101.02	-94.56	-77.69	-95.42	-29.12	-30.58	-11.9	-28.18	-8.73	-84.4	-58.28	-113.22	-130.16	-370.32	-326.59	-54.93	-33.22	-238.44

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
45.64	-617.74	-122.22

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-299.89	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-27.78	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	-0.69	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
Deciphera Pharmaceuticals DCPH	-60.12	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	3539.01	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	-13.49	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	-379.93	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	16.47	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	24.32	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-368.0	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-41.41	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	-1.18	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-63.97	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-71.74	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	-149.7	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	-34.58	$ 49.8	-	$ 4.48 B	Schweiz
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-88.5	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-439.8	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-69.03	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	-54.51	$ 31.27	-	$ 2.08 B	USA
Generation Bio Co. GBIO	-165.18	-	-	$ 344 M	USA
IMV IMV	-79.29	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	-123.17	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	-187.83	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-45.4	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	-7.7	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-76.42	-	5.93 %	$ 314 M	Canada
Enlivex Therapeutics Ltd. ENLV	-0.65	$ 0.67	-	$ 30.6 M	Israel
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-146.69	$ 2.84	-	$ 4.68 M	Israel
Esperion Therapeutics ESPR	-19.96	$ 3.15	-	$ 655 M	USA
Forte Biosciences FBRX	-115.85	$ 17.56	-	$ 227 M	USA
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
Eton Pharmaceuticals ETON	-3.23	$ 31.59	-	$ 850 M	USA
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-58.56	-	4.14 %	$ 49.1 M	USA